Clinical trial · Interventional
Depression Screening in Patients With Lung Cancer
Maximizing Utilization of Depression Screening in Lung Cancer Patients: A Randomized Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Screening tests may help doctors find depression in patients with lung cancer, allow doctors to recommend treatment for depression, and improve the patient's quality of life. PURPOSE: This randomized clinical trial is studying how well depression screening works when the results are or are not shared with patients with lung cancer and their doctor.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Depression | — | UNRESOLVED | — |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| counseling intervention | Other | — | UNRESOLVED |
| psychosocial assessment and care | Procedure | — | UNRESOLVED |
| screening questionnaire administration | Other | — | UNRESOLVED |
| study of socioeconomic and demographic variables | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- EXPERIMENTAL
- label
- Arm I (control)
- description
- Arm I (control): Patients complete screening questionnaires about their mood and experience with lung cancer once before and once after a visit with their physician. Neither the patient nor physician receives the screening results before the visit.
- interventionNames
- Other: counseling intervention
- Other: screening questionnaire administration
- Other: study of socioeconomic and demographic variables
- Procedure: psychosocial assessment and care
- type
- EXPERIMENTAL
- label
- Arm II
- description
- Arm II: Patients complete screening questionnaires as in arm I. Only the patient receives the screening results before their visit with the physician; the physician remains blinded to the results.
- interventionNames
- Other: counseling intervention
- Other: screening questionnaire administration
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Diagnosis of lung cancer * Prescreening distress thermometer score \> 3 * Zung Self-Rating Depression Scale (ZSDS) score ≥ 44 * No ZSDS response indicating suicidality PATIENT CHARACTERISTICS: * Able to understand English * No evidence of cognitive dysfunction that would impair giving consent PRIOR CONCURRENT THERAPY: * Not specified
References
Publications (0)
Data not yet available